Alberestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome, and graft-versus-host disease

摘要

The present invention relates to the treatment of organ rejection, in particular the treatment of lung transplant-associated bronchiolitis obliterans syndrome by administration of a neutrophil elastase inhibitor such as alberestat. The present invention also relates to the treatment of graft versus host disease.